A population-wide observational study to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows an association between tuberculosis (TB) and cancer, with those with current or previous TB more likely to have a diagnosis of a variety of cancers, including lung, blood, gynaecological and colorectal cancers.
Boundless Bio raises $100m as IPO market rouses – Pharmaceutical Technology
Share this article The IPO market is rebounding, with several pharma companies already listing this year. Image credit: Shutterstock/kenary820. US-based Boundless Bio will offer 6,250,000